• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Early prediction of chemotherapy-induced cardiotoxicity.

作者信息

Jones K A, Goodfield N E R

机构信息

Department of Nuclear Cardiology, Glasgow Royal Infirmary, Glasgow, UK.

School of Physics and Astronomy, University of Glasgow, Glasgow, UK.

出版信息

J Nucl Cardiol. 2023 Oct;30(5):2112-2113. doi: 10.1007/s12350-023-03251-1. Epub 2023 Mar 28.

DOI:10.1007/s12350-023-03251-1
PMID:36977898
Abstract
摘要

相似文献

1
Early prediction of chemotherapy-induced cardiotoxicity.化疗所致心脏毒性的早期预测
J Nucl Cardiol. 2023 Oct;30(5):2112-2113. doi: 10.1007/s12350-023-03251-1. Epub 2023 Mar 28.
2
Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment.全球纵向应变在一组接受蒽环类药物和/或曲妥珠单抗治疗的乳腺癌患者心脏毒性预测中的准确性
Arq Bras Cardiol. 2018 Feb;110(2):140-150. doi: 10.5935/abc.20180021.
3
Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.乳腺癌化疗所致心脏毒性的评估与管理：一项德尔菲研究
Clin Transl Oncol. 2017 Jan;19(1):91-104. doi: 10.1007/s12094-016-1508-y. Epub 2016 Apr 21.
4
Cancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumab.癌症与心血管疾病：利用新型超声心动图测量方法预测接受蒽环类药物和曲妥珠单抗治疗的乳腺癌患者后续的心脏毒性。
Curr Heart Fail Rep. 2014 Dec;11(4):366-73. doi: 10.1007/s11897-014-0214-8.
5
[Clinical observation on the anthracyclines-induced cardiotoxicity in patients with early-stage breast cancer].[蒽环类药物所致早期乳腺癌患者心脏毒性的临床观察]
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Dec 24;46(12):987-992. doi: 10.3760/cma.j.issn.0253-3758.2018.12.011.
6
Current views on anthracycline cardiotoxicity.关于蒽环类药物心脏毒性的当前观点。
Heart Fail Rev. 2016 Sep;21(5):621-34. doi: 10.1007/s10741-016-9564-5.
7
Left Ventricular Systolic Dysfunction Predicted By Early Troponin I Release After Anthracycline Based Chemotherapy In Breast Cancer Patients.蒽环类药物化疗后早期肌钙蛋白I释放预测乳腺癌患者左心室收缩功能障碍
J Ayub Med Coll Abbottabad. 2017 Apr-Jun;29(2):266-269.
8
Strain and left ventricular volumes for predicting cardiotoxicity: a life-saving approach in anthracycline cancer treatment?
Eur Heart J Cardiovasc Imaging. 2015 Sep;16(9):968-9. doi: 10.1093/ehjci/jev168. Epub 2015 Jul 22.
9
Applications of left ventricular strain measurements to patients undergoing chemotherapy.左心室应变测量在接受化疗患者中的应用。
Curr Opin Cardiol. 2018 Sep;33(5):493-497. doi: 10.1097/HCO.0000000000000541.
10
Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity.基于低剂量蒽环类药物化疗时评估整体纵向应变，以预测后续心脏毒性。
Eur Heart J Cardiovasc Imaging. 2017 Apr 1;18(4):392-401. doi: 10.1093/ehjci/jew223.

引用本文的文献

1
Traditional Chinese medicine as a protective strategy against chemotherapy-induced cardiotoxicity: An overview of the literature.中药作为化疗所致心脏毒性的一种保护策略：文献综述
J Tradit Complement Med. 2024 Jun 22;15(2):107-118. doi: 10.1016/j.jtcme.2024.06.010. eCollection 2025 Mar.

本文引用的文献

1
Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy.应变引导的潜在心脏毒性癌症治疗管理。
J Am Coll Cardiol. 2021 Feb 2;77(4):392-401. doi: 10.1016/j.jacc.2020.11.020. Epub 2020 Nov 18.
2
The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review.心脏磁共振成像在乳腺癌患者治疗后心脏毒性检测与监测中的作用：一项综述
Heart Fail Rev. 2021 May;26(3):679-697. doi: 10.1007/s10741-020-10028-y. Epub 2020 Oct 7.
3
Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy.
放射性核素心室造影相位分析用于正在接受心脏毒性癌症治疗的患者的危险分层。
J Nucl Cardiol. 2022 Apr;29(2):581-589. doi: 10.1007/s12350-020-02277-z. Epub 2020 Aug 3.
4
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis.左心室整体纵向应变评估对化疗诱导性心脏毒性早期预测的预后价值：系统评价和荟萃分析。
JAMA Cardiol. 2019 Oct 1;4(10):1007-1018. doi: 10.1001/jamacardio.2019.2952.
5
Diastolic dysfunction can precede systolic dysfunction on MUGA in cancer patients receiving trastuzumab-based therapy.在接受基于曲妥珠单抗治疗的癌症患者中，门控心血池显像（MUGA）检查时舒张功能障碍可能先于收缩功能障碍出现。
Nucl Med Commun. 2019 Jan;40(1):22-29. doi: 10.1097/MNM.0000000000000941.
6
Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer.乳腺癌内乳链放疗和蒽环类化疗后的心血管疾病发病率。
Br J Cancer. 2018 Aug;119(4):408-418. doi: 10.1038/s41416-018-0159-x. Epub 2018 Aug 1.
7
Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA).在曲妥珠单抗引起的心脏毒性中，舒张功能障碍是否先于收缩功能障碍？采用多门控放射性核素血管造影（MUGA）进行评估。
J Nucl Cardiol. 2016 Aug;23(4):824-32. doi: 10.1007/s12350-015-0164-x. Epub 2015 Jun 6.
8
Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer.基线舒张功能障碍作为蒽环类辅助化疗后曲妥珠单抗相关心脏毒性的预测因素。
Breast Cancer Res Treat. 2011 Dec;130(3):845-54. doi: 10.1007/s10549-011-1714-9. Epub 2011 Sep 15.
9
Does left ventricular diastolic function deteriorate earlier than left ventricular systolic function in anthracycline cardiotoxicity?在蒽环类药物心脏毒性中，左心室舒张功能是否比左心室收缩功能更早恶化？
Hell J Nucl Med. 2010 Sep-Dec;13(3):233-7.
10
Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.乳腺癌10年幸存者患心血管疾病的长期风险。
J Natl Cancer Inst. 2007 Mar 7;99(5):365-75. doi: 10.1093/jnci/djk064.